Reactive oxygen species mediate oxidized low-density lipoprotein-induced inhibition of oct-4 expression and endothelial differentiation of bone marrow stem cells

Antioxid Redox Signal. 2010 Dec 15;13(12):1845-56. doi: 10.1089/ars.2010.3156. Epub 2010 Oct 12.

Abstract

This study was to test the hypothesis that oxidized low-density lipoprotein (ox-LDL) modified the behavior of bone marrow stem cells, including proliferation, Oct-4 expression, and their endothelial differentiation through reactive oxygen species (ROS) formation in vitro. Rat bone marrow multipotent adult progenitor cells (MAPCs) were treated with ox-LDL with or without the antioxidant N-acetylcysteine (NAC). Ox-LDL generated a significant amount of ROS in the culture system as measured with electron paramagnetic resonance spectroscopy, and substantially inhibited the proliferation, Oct-4 expression, and endothelial differentiation of MAPCs. ROS production from ox-LDL in the culture system was completely prevented by NAC (1 mM). NAC treatment completely restored endothelial differentiation potential of MAPCs that was diminished by low-dose ox-LDL. NAC also significantly, but not completely, reversed the inhibitory effect of ox-LDL on proliferation and Oct-4 expression in MAPCs. NAC treatment only slightly restored Akt phosphorylation impaired by ox-LDL in the cells. ROS formation was important in the action of ox-LDL on MAPCs, including Oct-4 expression, proliferation, and endothelial differentiation. However, other mechanism(s) like Akt signaling and apoptosis might also play a critical role in mediating the effect of ox-LDL on these cells.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetylcysteine / pharmacology
  • Animals
  • Antioxidants / pharmacology
  • Blotting, Western
  • Cell Differentiation / drug effects*
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Electron Spin Resonance Spectroscopy
  • Endothelial Cells* / cytology
  • Endothelial Cells* / drug effects
  • Flow Cytometry
  • Gene Expression Regulation / drug effects*
  • Humans
  • Lipoproteins, LDL / pharmacology*
  • Multipotent Stem Cells* / cytology
  • Multipotent Stem Cells* / drug effects
  • Octamer Transcription Factor-3 / metabolism*
  • Rats
  • Reactive Oxygen Species / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Antioxidants
  • Lipoproteins, LDL
  • Octamer Transcription Factor-3
  • Reactive Oxygen Species
  • oxidized low density lipoprotein
  • Acetylcysteine